SRP6039 Sigma-Aldrich

Pro-MMP-13 human

recombinant, expressed in Sf9 cells, ≥95% (SDS-PAGE)

Synonym: MMP recombinant, MMP13, Matrix metalloproteinase-13, procollagenase 3



Related Categories Cell Analysis, Cell Biology, Cell Signaling and Neuroscience, Cytoskeleton and Extracellular Matrix, Extracellular Matrix,
biological source   human
recombinant   expressed in Sf9 cells
assay   ≥95% (SDS-PAGE)
form   liquid
mol wt   53.820 kDa
packaging   pkg of 10 μg
concentration   ~100 μg/mL
impurities   Endotoxin, tested
NCBI accession no.   P45452
shipped in   wet ice
storage temp.   −70°C
Gene Information   human ... MMP13(4322)


General description

MMP13 (matrix metalloproteinase13) was first identified in 1994 in human breast cancer. It is produced as an inactive proenzyme, and is activated by the cleavage of its N-terminal region. MMPs constitute a single protein superfamily, which are further classified as collagenases, gelatinases, and stromelysins. Humans contain nine MMPs, and MMP13 is a member of the collagenases subfamily, and is also known as collagenase 3. MMP13 gene is localized to the human chromosome location 11q14.3–23.2, which houses the nine MMP genes.

Biochem/physiol Actions

MMP13 (matrix metalloproteinase13) functions against different types of ECM (extracellular matrix) components. It gets activated by and activates multiple MMPs, and hence, has a central role in the MMP cascade. This protein is frequently expressed in colorectal cancer (CRC), and this expression is linked with poor survival in CRC. MMP13 expression is absent in normal breast tissue, but is present in breast carcinoma suggesting its role in tumorigenesis. The expression of this protein can serve as a marker for tumor invasiveness, as its expression is induced during metastasis of multiple types of cancers, including squamous cell carcinomas of the head and neck, and this expression is usually linked to poor prognosis. Missense mutation in this gene results in the autosomal dominant disorder called Missouri type of human spondyloepimetaphyseal dysplasia (SEMDMO), which is characterized by abnormal growth and modeling of vertebrae and long bones.

Physical form

In 50 mM Tris-HCl, pH 7; 250 mM NaCl; 5 mM CaCl2; 1 mM ZnCl2

Safety & Documentation

Safety Information

GHS09  GHS09
Hazard statements 
NONH for all modes of transport
WGK Germany 
Flash Point(F) 
Not applicable
Flash Point(C) 
Not applicable


Certificate of Analysis (COA)

Please Enter a Lot Number

Request a Serum Sample
Protocols & Articles
Peer-Reviewed Papers


Related Products

Technical Service:

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Bulk Ordering & Pricing:

Need larger quantities for your development, manufacturing or research applications?